findmyKOL
Clinical trialNCT04865419TerminatedPhase 1Interventional

Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies

SponsorAstraZenecaEnrollment46Haematological Malignancies
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Research Site

    Melbourne, Australia

  • Research Site

    Parkville, Australia

France
  • Research Site

    Pessac, France

Germany
  • Research Site

    Aachen, Germany

  • Research Site

    Heidelberg, Germany

  • Research Site

    Kiel, Germany

Italy
  • Research Site

    Bologna, Italy

  • Research Site

    Meldola, Italy

  • Research Site

    Rozzano, Italy

South Korea
  • Research Site

    Busan, South Korea

United States
  • Research Site

    Duarte, California, United States

  • Research Site

    Jacksonville, Florida, United States

  • Research Site

    Chicago, Illinois, United States

  • Research Site

    Columbus, Ohio, United States

  • Research Site

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
11 Jun 2021
Primary completion
8 Aug 2023
Completion
8 Aug 2023
Last update posted
15 Jun 2025
Registered enrollment
46
Registry id
NCT04865419

Cross-registrations

EU-CTR / CTIS (EudraCT)2020-005106-25

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.